Press release
Eosinophilic Disorders Market Specialized New Report, See Growth Acceleration From 2024-2031 | Novartis A.G, GlaxoSmithKline Plc., Teva Pharmaceutical
The Eosinophilic Disorders Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/eosinophilic-disorders-market
What is the projected growth rate (CAGR) of the Global Eosinophilic Disorders market from 2024 to 2031, and what is the market value expected to change by 2031?
The global eosinophilic disorders market reached US$ 150 million in 2023 and is expected to reach US$ 278 million by 2031 growing with a CAGR of 7.1% during the forecast period 2024-2031.
Eosinophilic disorders are a group of conditions characterized by an elevated level of eosinophils, a type of white blood cell, in the blood or tissues. Eosinophils are involved in allergic reactions and immune responses, and their abnormal accumulation can lead to inflammation and tissue damage. These disorders can affect various organs, including the skin, lungs, gastrointestinal system, and heart. Examples include eosinophilic asthma, eosinophilic esophagitis, and hypereosinophilic syndrome. Treatment often involves medications like corticosteroids or other immunosuppressants to reduce eosinophil levels and manage symptoms.
Key Developments:
In February 2024, Takeda announced that the U.S. Food and Drug Administration (FDA) approved EOHILIA (budesonide oral suspension), the first FDA-approved oral therapy for treating eosinophilic esophagitis (EoE) in individuals aged 11 and older.
In February 2024, Phase III data from the MANDARA study, published in the New England Journal of Medicine, demonstrated that remission is a feasible goal in eosinophilic granulomatosis with polyangiitis (EGPA) with FASENRA.
In July 2022, Areteia Therapeutics, Inc. launched as a clinical-stage biopharmaceutical company focused on providing asthma patients better disease control with its first potential oral therapy for eosinophilic asthma. The company's lead drug candidate, dexpramipexole, is an innovative oral eosinophil maturation inhibitor.
List of the Key Players in the Eosinophilic Disorders Market:
Novartis A.G, GlaxoSmithKline Plc., Teva Pharmaceutical, Pfizer Inc., AstraZeneca, Sanofi S.A, Curia, LGM Pharma, Henan Lihua Pharmaceuticals Ltd., and Hikma Pharmaceuticals
Research Process:
Both primary and secondary data sources have been used in the global Eosinophilic Disorders Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Eosinophilic Disorders Market:
By Type: Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Enteritis, Eosinophilic Colitis, Hypereosinophilic Syndrome
By Treatment: Medications, Dietary Therapy, Dilation, Others
By Distribution Channels: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
Regional Breakout:
The global Eosinophilic Disorders Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
✫ North America (U.S., Canada, Mexico)
✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=eosinophilic-disorders-market
This Report Unveils:
✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.
✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.
✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.
✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.
✔ Identify high-potential niche segments and regions poised for significant expansion.
✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.
✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Eosinophilic Disorders manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Eosinophilic Disorders in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Eosinophilic Disorders market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Eosinophilic Disorders market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/eosinophilic-disorders-market
Frequently Asked Questions
☞ What is the expected growth rate of the global Eosinophilic Disorders market for the forecast period?
☞ What are the key driving factors that are responsible to shape the fate of the Eosinophilic Disorders market during the forecast period?
☞ What will be the overall size of the market during the analysis period?
☞ What are the prominent market trends which influence the development of the Eosinophilic Disorders market across various regions?
☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Eosinophilic Disorders market?
☞ What are the major opportunities that the companies can get to attain success in the world?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Eosinophilic Disorders Market Specialized New Report, See Growth Acceleration From 2024-2031 | Novartis A.G, GlaxoSmithKline Plc., Teva Pharmaceutical here
News-ID: 3732951 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Level and Flow Sensor Market to Reach USD 27.07 Billion by 2032 at 8.73% CAGR | …
The Level and Flow Sensor Market was valued at USD 16.97 billion in 2024 and is projected to reach USD 27.07 billion by 2032, expanding at a CAGR of 8.73% during the forecast period from 2025 to 2032. This strong growth reflects rising global demand for accurate fluid measurement and monitoring across industries such as oil and gas, water and wastewater, chemicals, food and beverage, pharmaceuticals, and industrial manufacturing. As…
BPO Market is Expected to reach USD 695.77 billion by 2033 with a CAGR of 9.9%, …
The global Business Process Outsourcing Market size was estimated at USD 328.37 billion in 2025 and is projected to reach USD 695.77 billion by 2033, growing at a CAGR of 9.9% from 2026 to 2033. The rapid adoption of digital transformation initiatives is boosting BPO demand as organizations deploy cloud platforms, AI-driven analytics, and automation tools.
The Business Process Outsourcing market is growing due to rising demand for cost efficiency, digital…
Neuromorphic Computing Market Set for Explosive Growth to US$ 6,801.9 Million by …
The Global Neuromorphic Computing Market reached USD 48.3 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,801.9 million by 2030, exhibiting a CAGR of 91.5% during the forecast period (2024-2031).
Market growth is driven by surging demand for energy-efficient AI processing, mimicking human brain neural structures for edge computing applications. Advancements in spiking neural networks, rising investments in brain-inspired hardware by tech giants like…
Feed Vitamins Market size is expected to reach US$ 5.37 billion, dominated by As …
Global Feed Vitamins Market reached US$ 3.45 billion in 2022 and is expected to reach US$ 5.37 billion by 2031, growing with a CAGR of 5.71% during the forecast period 2024-2031.
Feed Vitamins Market Growth Reason: Rising demand for livestock nutrition, increasing awareness of animal health, and the need for enhanced productivity and immunity are driving global adoption of fortified feed vitamins.
Get a Free Sample PDF Of This Report (Get Higher…
More Releases for Eosinophilic
Eosinophilic Esophagitis Market to Surge to USD 4.1 Billion by 2034
Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus, characterized by eosinophil infiltration, difficulty swallowing, food impaction, and chest pain. Once considered rare, EoE has now emerged as one of the most common causes of dysphagia in children and adults, particularly in developed nations. Strong associations with allergic conditions such as asthma, eczema, and food allergies underscore its complex immunological nature.
Download Full PDF Sample Copy of Market…
Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2030
The eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the…
Severe Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2 …
The severe eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Eosinophilic Esophagitis Pipeline, Clinical Trials Assessment, Emerging Therapie …
DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Eosinophilic Esophagitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Eosinophilic Esophagitis research. Learn more about…
Severe Eosinophilic Asthma Treatment Market Outlook and Future Projections for 2 …
The severe eosinophilic asthma treatment market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines…
Eosinophilic Granulomatosis Treatment Market Size and Overview Upto 2028|
The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Eosinophilic Granulomatosis Treatment market. It includes Porter's Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Eosinophilic Granulomatosis Treatment Market. We have provided a deep analysis of the vendor landscape to give…
